Metaproterenol Sulfate and Metreleptin

• Generic Name: metaproterenol
• Dosage Forms: n.a.
• Other Brand Names:

  Metaprel, Alupent

Symptomatic management of bronchospasm in patients with reversible, obstructive airway disease (e.g., asthma). Manufacturer recommends against use with other β-adrenergic bronchodilators. (See Specific Drugs under Interactions.)

Current asthma management guidelines and most clinicians recommend anti-inflammatory therapy with an orally inhaled corticosteroid as first-line therapy for long-term control of persistent asthma, supplemented by intermittent, as-needed use of a short-acting, inhaled β2-agonist.

The National Asthma Education and Prevention Program (NAEPP) does not recommend nonselective β-adrenergic agonists, including metaproterenol, for treatment of asthma because of the associated potential for excessive cardiac stimulation, particularly in high doses.

Symptomatic management of reversible bronchospasm in patients with COPD, including chronic bronchitis and emphysema. Manufacturer recommends against use with other β-adrenergic bronchodilators. (See Specific Drugs under Interactions.)

• Generic Name: metreleptin
• Dosage Forms: n.a.
• Other Brand Names: Myalept

• It is used to treat problems caused by not having enough of a certain hormone (leptin) in the body. It is only for use in people with congenital or acquired generalized lipodystrophy.